Research News

New Clues About Origins of Ovarian Cancer

According to research published in March 6 in the journal Nature, researchers have discovered a possible origin of epithelial ovarian cancer…

Read on

USPSTF Releases Draft Statement on Risk Assessment for BRCA-Related Cancer

On Tuesday, April 2, the U.S. Preventive Services Task Force (USPSTF) released its draft recommendation statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer…

Read on

Depression and Anxiety Drug May Ease Neuropathy from Chemo

Research published today in the Journal of the American Medical Association showed that the depression and anxiety drug duloxetine effectively treated painful chemotherapy-induced peripheral neuropathy…

Read on

Report from the Society of Gynecologic Oncology 2013 Annual Meeting

At this year’s Society of Gynecologic Oncology (SGO) Annual Meeting, numerous presentations and posters explored issues related to ovarian cancer, some of which are summarized below…

Read on

New Genetic Markers for Ovarian Cancer Discovered

A collaboration of more than 130 institutions analyzing data from more than 200,000 people found two new genetic markers increasing a woman’s risk of developing ovarian cancer…

Read on

OCRF Research Identifies Genetic Variations Increasing Ovarian Cancer Risk

As part of a huge international effort involving more than 100 institutions and genetic tests on 200,000 people, researchers have discovered dozens of signposts in DNA that can help reveal further a person’s risk for breast, ovarian or…

Read on

Night Shift Work May Increase Risk of Ovarian Cancer

A study by researchers from the Fred HutchinsonCancer Research Center in Seattle found that women working the night shift may be at higher risk for ovarian cancer…

Read on

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer

In research published online on March 11, 2013 in the Journal of Clinical Oncology, researchers report on the results of a phase III, double-blind, placebo-controlled multicenter study that evaluated whether using abagovomab as maintenance therapy…

Read on

News from the SGO Annual Meeting

From March 9-12, 2013 top women’s cancer doctors from all over the world met in Los Angeles for the Society of Gynecologic Oncology‘s Annual Meeting on Women’s Cancer…

Read on

IP Chemo Shows Survival Benefit

Two studies recently released show a survival benefit for intraperitoneal IP chemotherapy Women with the BRCA1 mutation given IP chemotherapy survived three years longer than those given IV chemotherapy. Read an article about the study here…

Read on

New York Times Reports on Flaws in Ovarian Cancer Care

The New York Times reported today on a study that found most women with ovarian cancer receive inadequate care…

Read on

Enrollees in Cancer Clinical Trials Usually Healthier

Often, patients enrolled in clinical trials live longer than those who are not, however, a new study shows that the survival benefit may be due to the patient’s health, not the treatment received in the clinical trial…

Read on